EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cannabis use patterns in drug-resistant and pharmacoresponsive epilepsy: Single tertiary referral center survey investigation

Danielle McDermott, Marielle L Darwin iD, Kirsten Fetrow, Ian Coulter, Kristal Biesecker iD, John A Thompson iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0281040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Danielle McDermott und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America. Hauptthemen laut MEDLINE: Cannabis, Epilepsy, Drug Resistant Epilepsy, Hallucinogens. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study sought to identify differences in cannabis use and perceptions about cannabis in mitigating seizure-related symptoms in patients with epilepsy, and to evaluate differences in these patterns between drug-resistant versus pharmacoresponsive epilepsy. A collection of self-report surveys completed by patients with epilepsy ( n = 76) were used to retrospectively compare differences in those with drug-resistant versus pharmacoresponsive epilepsy regarding 1) proportion who used cannabis, 2) frequency of use, 3) method of use, and 4) reason for use. A Cochran-Armitage test for trend indicated that of patients who used cannabis, a higher proportion of patients in the drug-resistant group used more frequently than in the pharmacoresponsive group. Almost half (48%) of those in the drug-resistant group reported daily use compared to approximately a third (36%) of those in the pharmacoresponsive group. Additionally, no patient in either group reported that cannabis was harmful in relation to seizure-related symptoms. Results from this study highlight the need for epilepsy providers to formally assess patients’ perceptions and use of non-prescribed cannabis to inform clinical care decisions, particularly in the drug-resistant epilepsy population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabisEpilepsyDrug Resistant EpilepsyHallucinogensHumansAnticonvulsantsRetrospective StudiesTertiary Care CentersSeizuresCannabinoid Receptor Agonists

Substanzen

AnticonvulsantsHallucinogensCannabinoid Receptor Agonists

Autor:innen und Institutionen

  • Department of Neurology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
  • Department of Neurosurgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
  • School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.

ORCID-Profile: Marielle L Darwin, Kristal Biesecker, John A Thompson

Zitieren

APA

McDermott, D., Darwin, M. L., Fetrow, K., Coulter, I., Biesecker, K., & Thompson, J. A. (2023). Cannabis use patterns in drug-resistant and pharmacoresponsive epilepsy: Single tertiary referral center survey investigation. PLOS ONE. https://doi.org/10.1371/journal.pone.0281040

Vancouver

McDermott D, Darwin ML, Fetrow K, Coulter I, Biesecker K, Thompson JA. Cannabis use patterns in drug-resistant and pharmacoresponsive epilepsy: Single tertiary referral center survey investigation. PLOS ONE. 2023. doi:10.1371/journal.pone.0281040

BibTeX
@article{McDermott2023,
  author = {McDermott, Danielle and Darwin, Marielle L and Fetrow, Kirsten and Coulter, Ian and Biesecker, Kristal and Thompson, John A},
  title = {Cannabis use patterns in drug-resistant and pharmacoresponsive epilepsy: Single tertiary referral center survey investigation},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0281040}
}
Kostenlos starten →